FGF9 is identified as an important epithelial-to-mesenchymal transition signal required for embryo development [36], furthermore, it has been reported to be expressed in various tumors, such as colon cancer, gastric carcinoma and lung carcinoma [37–39]. Here, FGF9 is linked to colonic neoplasm.